Last reviewed · How we verify
Organophosphate poisoning — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Pralidoxime Chloride (Autoinjector) | PRALIDOXIME | Baxter | Cholinesterase Reactivator | Acetylcholinesterase | 1964-01-01 | |
| Toxogonin | Toxogonin | Aya Sabry Mohamed Mohamed | Acetylcholinesterase |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 1 drug in Organophosphate poisoning
- Aya Sabry Mohamed Mohamed · 1 drug in Organophosphate poisoning
- Baxter · 1 drug in Organophosphate poisoning
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Organophosphate poisoning:
- Organophosphate poisoning treatment updates — RSS
- Organophosphate poisoning treatment updates — Atom
- Organophosphate poisoning treatment updates — JSON
Cite this brief
Drug Landscape (2026). Organophosphate poisoning — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/organophosphate-poisoning. Accessed 2026-06-10.
Related
- Organophosphate poisoning full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing